These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18182580)

  • 1. Use of hydroxyurea in prevention of stroke in children with sickle cell disease.
    Lefèvre N; Dufour D; Gulbis B; Lê PQ; Heijmans C; Ferster A
    Blood; 2008 Jan; 111(2):963-4; author reply 964. PubMed ID: 18182580
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.
    Zimmerman SA; Schultz WH; Burgett S; Mortier NA; Ware RE
    Blood; 2007 Aug; 110(3):1043-7. PubMed ID: 17429008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea.
    Grace RF; Su H; Sena L; Poussaint TY; Heeney MM; Gutierrez A
    Am J Hematol; 2010 Feb; 85(2):135-7. PubMed ID: 20052745
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
    Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
    Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease: role of transcranial Doppler ultrasound in stroke prophylaxis.
    Suliman H; Wali Y; Al Saadoon M; Zechariah M; William RR; Gujjar A; Pathare A
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):42-4. PubMed ID: 19125086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
    Estepp JH; Cong Z; Agodoa I; Kang G; Ding J; McCarville MB; Hankins JS; Wang WC
    Br J Haematol; 2021 Jul; 194(2):463-468. PubMed ID: 34131902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
    Mack AK; Thompson AA
    J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
    Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE
    Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease and transcranial Doppler imaging: inter-hemispheric differences in blood flow Doppler parameters.
    Krejza J; Chen R; Romanowicz G; Kwiatkowski JL; Ichord R; Arkuszewski M; Zimmerman R; Ohene-Frempong K; Desiderio L; Melhem ER
    Stroke; 2011 Jan; 42(1):81-6. PubMed ID: 21088242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
    Lagunju I; Brown BJ; Sodeinde O
    Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the role of hydroxyurea in children with sickle cell disease.
    Rogers ZR; Buchanan GR
    J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174
    [No Abstract]   [Full Text] [Related]  

  • 12. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 13. TCD methodology in children with sickle-cell anemia.
    Razumovsky AY
    Pediatr Radiol; 2002 Sep; 32(9):690-1; author reply 692-3. PubMed ID: 12422847
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial.
    Kwiatkowski JL; Granger S; Brambilla DJ; Brown RC; Miller ST; Adams RJ;
    Br J Haematol; 2006 Aug; 134(3):333-9. PubMed ID: 16848777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
    Galadanci NA; Umar Abdullahi S; Vance LD; Musa Tabari A; Ali S; Belonwu R; Salihu A; Amal Galadanci A; Wudil Jibir B; Bello-Manga H; Neville K; Kirkham FJ; Shyr Y; Phillips S; Covert BV; Kassim AA; Jordan LC; Aliyu MH; DeBaun MR
    Am J Hematol; 2017 Aug; 92(8):780-788. PubMed ID: 28439953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease.
    Ware RE; Zimmerman SA; Schultz WH
    Blood; 1999 Nov; 94(9):3022-6. PubMed ID: 10556185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial.
    Sánchez LM; Nieves RM; Latham T; Stuber S; Luden JR; Urcuyo GS; Berges ME; Florencio C; Gonzalez C; Del Villar P; Lane A; Schultz W; Jeste N; Mena R; Ware RE
    Blood Adv; 2018 Nov; 2(Suppl 1):50-53. PubMed ID: 30504201
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities.
    Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Hau I; Leveillé E; Vasile M; Kasbi F; Madhi F; Fourmaux C; Biscardi S; Gluckman E; Socié G; Dalle JH; Epaud R; Pondarré C
    Blood; 2016 Apr; 127(14):1814-22. PubMed ID: 26851292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
    Ghafuri DL; Abdullahi SU; Dambatta AH; Galadanci J; Tabari MA; Bello-Manga H; Idris N; Inuwa H; Tijjani A; Suleiman AA; Jibir BW; Gambo S; Gambo AI; Khalifa Y; Haliru L; Abdulrasheed S; Zakari MA; Greene BC; Trevathan E; Jordan LC; Aliyu MH; Baumann AA; DeBaun MR
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e56-e61. PubMed ID: 34001783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.